Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Columbia Laboratories, Inc.
Columbia Laboratories Reports Fourth Quarter and Year-End 2008 Financial Results
March 21st, 2009
Columbia Laboratories, Inc. (Nasdaq: CBRX) announced results for the fourth quarter and fiscal year ended December 31, 2008. 2008 Highlights Net revenues increased 23% from 2007 to $36.3 million. Net revenues from CRINONE® and PROCHIEVE® (Progesterone Products), increased 18% from 2007 to $24.1 million. Improved net loss of $14.1 million ($0.27 per basic and diluted share) versus a net loss of $14.3 million ($0.28 per basic and diluted share) in 2007. Fourth Quarter Highlights Net revenues of $7.1 million. Net revenues from US sales of CRINONE® and PROCHIEVE® increased 11% from the fourth quarter of 2007. Net...
Source: Law & Health Weekly (2009-03-21)
|
